Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19
Background: Many treatments are being assessed for repurposing to treat coronavirus disease 2019 (COVID-19). One drug that has shown promising results in vitro is nitazoxanide. Unlike other postulated drugs, nitazoxanide shows a high ratio of maximum plasma concentration (Cmax), after 1 day of 500 m...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2020-04-01
|
| Series: | Journal of Virus Eradication |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2055664020300170 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|